GlassScriptPhysician profile
Shahid Mansoor
NPI 1710072012
$256.42
in general payments reported to CMS, 2019-2025
10 companies · $30.00 in 2025
The $30.00 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.95 · 2020: $21.91 · 2022: $13.09 · 2023: $24.09 · 2024: $104 · 2025: $30.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $158.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $54.09 | 2023-2025 | Azstarys |
| Sanofi Pasteur INC. | $41.23 | 2019-2022 | |
| Neurelis, INC. | $37.12 | 2024 | Valtoco |
| Takeda Pharmaceuticals U.S.A., INC. | $21.91 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $20.66 | 2024 | Flumist Quadrivalent |
| Sanofi-Aventis U.S. LLC | $19.45 | 2024 | |
| Merck Sharp & Dohme LLC | $18.61 | 2019 | |
| Shire North American Group INC | $16.20 | 2019 | |
| Ironshore Pharmaceuticals INC. | $14.05 | 2024 | |
| Aytu Biopharma, INC. | $13.10 | 2024 | Karbinal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shahid Mansoor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.